Terms: = Uterine cancer AND BTG1, P62324, 694, ENSG00000133639
61 results:
1. Race, Prevalence of POLE and POLD1 Alterations, and Survival Among Patients With Endometrial cancer.
Zheng S; Donnelly ED; Strauss JB
JAMA Netw Open; 2024 Jan; 7(1):e2351906. PubMed ID: 38231514
[TBL] [Abstract] [Full Text] [Related]
2. Diagnostic Accuracy of Ultrasound in the Diagnosis of uterine Leiomyomas and Sarcomas.
Raffone A; Raimondo D; Neola D; Travaglino A; Raspollini A; Giorgi M; Santoro A; De Meis L; Zannoni GF; Seracchioli R; Casadio P; Guida M
J Minim Invasive Gynecol; 2024 Jan; 31(1):28-36.e1. PubMed ID: 37778636
[TBL] [Abstract] [Full Text] [Related]
3. Public health impact and cost-effectiveness of switching from bivalent to nonavalent vaccine for human papillomavirus in Norway: incorporating the full health impact of all HPV-related diseases.
Diakite I; Nguyen S; Sabale U; Pavelyev A; Saxena K; Tajik AA; Wang W; Palmer C
J Med Econ; 2023; 26(1):1085-1098. PubMed ID: 37608730
[TBL] [Abstract] [Full Text] [Related]
4. Prediction of postoperative reintervention risk for uterine fibroids using clinical-imaging features and T2WI radiomics before high-intensity focused ultrasound ablation.
Qin S; Lin Z; Liu N; Zheng Y; Jia Q; Huang X
Int J Hyperthermia; 2023; 40(1):2226847. PubMed ID: 37394476
[TBL] [Abstract] [Full Text] [Related]
5. Construction of refined staging classification systems integrating FIGO/T-categories and corpus uterine invasion for non-metastatic cervical cancer.
Huang XD; Chen K; Shi L; Luo YS; Ou-Yang Y; Li JY; Huo LQ; Huang L; Chen FP; Cao XP
Cancer Med; 2023 Jul; 12(14):15079-15089. PubMed ID: 37326385
[TBL] [Abstract] [Full Text] [Related]
6. Lifetime prevalence and adherence rate of cervical cancer screening among women living with HIV: a systematic review and meta-analysis.
Gao X; Zhang W; Sun J; Adeloye D; Jin H; Rudan I; Song P; Jin M
J Int AIDS Soc; 2023 May; 26(5):e26090. PubMed ID: 37247380
[TBL] [Abstract] [Full Text] [Related]
7. Unsuspected placenta accreta spectrum at vaginal delivery: assessment of incidence, characteristics, and maternal morbidity.
Rau AR; Youssefzadeh AC; Matsuzaki S; Mandelbaum RS; Ouzounian JG; Matsuo K
Am J Obstet Gynecol MFM; 2023 May; 5(5):100805. PubMed ID: 36774226
[TBL] [Abstract] [Full Text] [Related]
8. Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancer.
Jamieson A; Huvila J; Leung S; Chiu D; Thompson EF; Lum A; Kinloch M; Helpman L; Salvador S; Vicus D; Kean S; Samouelian V; Grondin K; Irving J; Offman S; Parra-Herran C; Lau S; Scott S; Plante M; McConechy MK; Huntsman DG; Talhouk A; Kommoss S; Gilks CB; McAlpine JN
Gynecol Oncol; 2023 Mar; 170():282-289. PubMed ID: 36753816
[TBL] [Abstract] [Full Text] [Related]
9. Higher clearance rates of multiple HPV infections may explain their lower risk of HSIL: A retrospective study in Wenzhou, China.
Ni X; Hu J; Huang Y; Tao J; Zhu H
J Med Virol; 2023 Feb; 95(2):e28526. PubMed ID: 36698241
[TBL] [Abstract] [Full Text] [Related]
10. Discrepancy of human papillomavirus vaccine uptake and intent between girls 9-14 and their mothers in a pilot region of Shanghai, China.
Guo Q; Zhou W; Wen X; Lu J; Lu X; Lu Y
Hum Vaccin Immunother; 2022 Nov; 18(6):2132801. PubMed ID: 36306482
[TBL] [Abstract] [Full Text] [Related]
11. A novel ultrasound probe calibration method for multimodal image guidance of needle placement in cervical cancer brachytherapy.
Pu G; Jiang S; Yang Z; Hu Y; Liu Z
Phys Med; 2022 Aug; 100():81-89. PubMed ID: 35759943
[TBL] [Abstract] [Full Text] [Related]
12. Genetic polymorphisms in DNA repair genes and their association with risk of cervical cancer: A systematic review and meta-analysis.
Shao X; Yang X; Liu Y; Song Q; Pan X; Chen W; Jiang W; Xu D; Song Y; Chen R
J Obstet Gynaecol Res; 2022 Sep; 48(9):2405-2418. PubMed ID: 35732591
[TBL] [Abstract] [Full Text] [Related]
13. A Research Study to Measure the Efficacy of Terminating Cervical cancer via Customized Optimum Pathway.
Zhang X; Ma H; Lu X; Zhang Z
J Healthc Eng; 2022; 2022():7872915. PubMed ID: 35340234
[TBL] [Abstract] [Full Text] [Related]
14. A Meta-Analysis for Association of XRCC3 rs861539, MTHFR rs1801133, IL-6 rs1800795, IL-12B rs3212227, TNF-α rs1800629, and TLR9 rs352140 Polymorphisms with Susceptibility to Cervical Carcinoma.
Parsaeian SF; Asadian F; Karimi-Zarchi M; Setayesh S; Javaheri A; Tabatabaie RS; Dastgheib SA; Golestanpour H; Neamatzadeh H
Asian Pac J Cancer Prev; 2021 Nov; 22(11):3419-3431. PubMed ID: 34837895
[TBL] [Abstract] [Full Text] [Related]
15. Prevalence, characteristics, and distribution of HPV genotypes in women from Zhejiang Province, 2016-2020.
Yan X; Shen L; Xiao Y; Wang Q; Li F; Qian Y
Virol J; 2021 Oct; 18(1):208. PubMed ID: 34670576
[TBL] [Abstract] [Full Text] [Related]
16. Comparison between laparoscopic and abdominal radical hysterectomy for low-risk cervical cancer: a multicentre retrospective study.
Li Z; Chen C; Liu P; Lu A; Zhao H; Zhan X; Duan H; Li P; Zhao W; Yao J; Li D; Jiang H; Liu M; Bin X; Lang J
Arch Gynecol Obstet; 2022 Feb; 305(2):449-458. PubMed ID: 34406459
[TBL] [Abstract] [Full Text] [Related]
17. Non-aspirin NSAID use and mortality of endometrial cancer. A nationwide cohort study.
Sperling CD; Verdoodt F; Aalborg GL; Dehlendorff C; Friis S; Kjaer SK
Cancer Causes Control; 2021 May; 32(5):515-523. PubMed ID: 33620641
[TBL] [Abstract] [Full Text] [Related]
18. An Analysis of Contemporary Oncology Randomized Clinical Trials From Low/Middle-Income vs High-Income Countries.
Wells JC; Sharma S; Del Paggio JC; Hopman WM; Gyawali B; Mukherji D; Hammad N; Pramesh CS; Aggarwal A; Sullivan R; Booth CM
JAMA Oncol; 2021 Mar; 7(3):379-385. PubMed ID: 33507236
[TBL] [Abstract] [Full Text] [Related]
19. Polymorphisms and haplotypes of TLR4, TLR9 and CYP1A1 genes possibly interfere with high-risk human papillomavirus infection and cervical cancer susceptibility in Jharkhand, India.
Nath N; Mishra P; Panda AK; Mishra R
Int Immunopharmacol; 2020 Nov; 88():106925. PubMed ID: 32871478
[TBL] [Abstract] [Full Text] [Related]
20. Is the revised 2018 FIGO staging system for cervical cancer more prognostic than the 2009 FIGO staging system for women previously staged as IB disease?
Ayhan A; Aslan K; Bulut AN; Akilli H; Öz M; Haberal A; Meydanli MM
Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():209-214. PubMed ID: 31325847
[TBL] [Abstract] [Full Text] [Related]
[Next]
